1/20
03:13 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/20
12:47 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
1/20
12:47 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $66.00 price target on the stock.
1/20
12:32 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
1/20
12:32 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
1/7
10:38 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
1/7
10:38 am
legn
Rating for LEGN
Medium
Report
Rating for LEGN
1/7
09:00 am
legn
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $75.00 price target on the stock.
Medium
Report
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $75.00 price target on the stock.
1/7
08:33 am
legn
Legend Biotech initiated with an Outperform at Oppenheimer
Medium
Report
Legend Biotech initiated with an Outperform at Oppenheimer
1/7
08:33 am
legn
Legend Biotech initiated with an Outperform at Oppenheimer
Medium
Report
Legend Biotech initiated with an Outperform at Oppenheimer
12/17
09:53 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
12/12
12:14 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
12/12
12:14 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
12/8
11:02 am
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/8
11:02 am
legn
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Legend Biotech (NASDAQ:LEGN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/8
10:16 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
12/8
08:13 am
legn
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/26
07:03 am
legn
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/13
03:27 pm
legn
Rating for LEGN
Report
Rating for LEGN
11/13
03:27 pm
legn
Rating for LEGN
Report
Rating for LEGN
11/13
12:35 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
11/13
12:35 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
11/13
09:07 am
legn
Rating for LEGN
Low
Report
Rating for LEGN